| The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy LA Honigberg, AM Smith, M Sirisawad, E Verner, D Loury, B Chang, S Li, ... Proceedings of the National Academy of Sciences 107 (29), 13075-13080, 2010 | 1734 | 2010 |
| Evaluation of a 6‐month chemotherapy protocol with no maintenance therapy for dogs with lymphoma LD Garrett, DH Thamm, R Chun, R Dudley, DM Vail Journal of veterinary internal medicine 16 (6), 704-709, 2002 | 392 | 2002 |
| Response evaluation criteria for solid tumours in dogs (v1. 0): a Veterinary Cooperative Oncology Group (VCOG) consensus document SM Nguyen, DH Thamm, DM Vail, CA London Veterinary and comparative oncology 13 (3), 176-183, 2015 | 387 | 2015 |
| Autophagy and cancer therapy A Thorburn, DH Thamm, DL Gustafson Molecular pharmacology 85 (6), 830-838, 2014 | 344 | 2014 |
| Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer MD Rowe, DH Thamm, SL Kraft, SG Boyes Biomacromolecules 10 (4), 983-993, 2009 | 297 | 2009 |
| Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours C London, T Mathie, N Stingle, C Clifford, S Haney, MK Klein, L Beaver, ... Veterinary and comparative oncology 10 (3), 194-205, 2012 | 277 | 2012 |
| Prednisone and vinblastine chemotherapy for canine mast cell tumor—41 cases (1992–1997) DH Thamm, EA Mauldin, DM Vail Journal of veterinary internal medicine 13 (5), 491-497, 1999 | 247 | 1999 |
| An asymmetric synthesis of 1, 2, 4-trioxane anticancer agents via desymmetrization of peroxyquinols through a Brønsted acid catalysis cascade DM Rubush, MA Morges, BJ Rose, DH Thamm, T Rovis Journal of the American Chemical Society 134 (33), 13554-13557, 2012 | 211 | 2012 |
| Small animal clinical oncology DM Vail, DH Thamm, JM Liptak Philadelphia, WB Saunders 28, 611-624, 2001 | 199 | 2001 |
| Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases DH Thamm, MM Turek, DM Vail Journal of Veterinary Medical Science 68 (6), 581-587, 2006 | 190 | 2006 |
| Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation DH Thamm, ID Kurzman, I King, Z Li, M Sznol, RR Dubielzig, DM Vail, ... Clinical cancer research 11 (13), 4827-4834, 2005 | 188 | 2005 |
| Comparison of carboplatin and doxorubicin‐based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma LE Selmic, JH Burton, DH Thamm, SJ Withrow, SE Lana Journal of veterinary internal medicine 28 (2), 554-563, 2014 | 177 | 2014 |
| Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases … MN Mullins, WS Dernell, SJ Withrow, EJ Ehrhart, DH Thamm, SE Lana Journal of the American Veterinary Medical Association 228 (1), 91-95, 2006 | 175 | 2006 |
| Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma RA Barnard, LA Wittenburg, RK Amaravadi, DL Gustafson, A Thorburn, ... Autophagy 10 (8), 1415-1425, 2014 | 174 | 2014 |
| Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985–1995) LE Williams, JM Gliatto, RK Dodge, JL Johnson, RM Gamblin, DH Thamm, ... Journal of the American Veterinary Medical Association 223 (6), 825-831, 2003 | 172 | 2003 |
| Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial … DM Vail, R Chun, DH Thamm, LD Garrett, AJ Cooley, JE Obradovich Clinical cancer research: an official journal of the American Association …, 1998 | 160 | 1998 |
| Bisphosphonate conjugation for bone specific drug targeting KB Farrell, A Karpeisky, DH Thamm, S Zinnen Bone reports 9, 47-60, 2018 | 150 | 2018 |
| Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers MD Rowe, CC Chang, DH Thamm, SL Kraft, JF Harmon Jr, AP Vogt, ... Langmuir 25 (16), 9487-9499, 2009 | 145 | 2009 |
| Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumour and a proposed classification system for the evaluation of node metastasis KM Weishaar, DH Thamm, DR Worley, DA Kamstock Journal of Comparative Pathology 151 (4), 329-338, 2014 | 143 | 2014 |
| Low‐dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma JH Burton, L Mitchell, DH Thamm, SW Dow, BJ Biller Journal of Veterinary Internal Medicine 25 (4), 920-926, 2011 | 142 | 2011 |
Lee HonigbergVerified email at gene.com
